Clinical Trial Update: Covid-19 Vaccine Immune Response in Multiple Sclerosis

View source ↗

Summary

Clinical trial evaluating immune response to a Covid-19 vaccine in people with Multiple Sclerosis; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University Hospitals of North Midlands NHS Trust | Conditions: Multiple Sclerosis | Status: ACTIVE_NOT_RECRUITING